A dietary supplement is defined as a product taken by mouth containing a dietary ingredient intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs or other botanicals, and amino acids.
Select an Issue
Dietary Supplement Resource Library
Explore our list of resources to learn more about the dietary supplement category and how it is regulated by the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC).
The Dietary Supplements Access Act of 2023 is bipartisan legislation intended to give American consumers increased flexibility to best determine how to use their pre-tax dollars to stay healthy.
It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.
CHPA has reviewed the findings of the meeting of the World Health Organization Expert Committee on Drug Dependence. CHPA agrees with the Committee's recommendations.
Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics).
Herein, CHPA provides feedback on the Food and Drug Administration’s Nutrition Innovation Strategy, particularly as it relates to the agency’s development and implementation of a consumer education campaign.
The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated version of the Standardized Information on Dietary Ingredients (SIDI TM) Protocol.
Herein, CHPA provides feedback on the Agricultural Marketing Service (AMS) request for comments on a Proposed Rule to establish the national mandatory bioengineered food disclosure standard.
Best practices for consumers looking to make evidence-informed decisions when shopping for dietary supplements, including avoiding red-flag ingredients such as SARMs.
We applaud FDA for focusing their enforcement efforts on homeopathic drug products that do not meet manufacturing standards, contain harmful ingredients, or are OTC products with prescription indications.
CHPA appreciates that FDA has taken the time to review the data associated with certain isolated or synthetic carbohydrates not listed as a dietary fiber and looks forward to engaging with FDA in efforts to clarify and improve the regulation of all dietary supplements.
CHPA submitted comments this week to the Food and Drug Administration regarding the proposed development of an authorized list of dietary ingredients marketed prior to the Dietary Supplement Health and Education Act.
